Instituto RosenbuschBUE:ROSE 39 Days Inventory is 135.82 as of Dec. 2025, which is 48% below its 10-year median of 261.82. GuruFocus rates BUE:ROSE with a GF Score™ of 39/100 and a GF Value™ of ARS62.05 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 919 Drug Manufacturers companies, Instituto Rosenbusch ranks better than 52.45% on this metric.
The historical rank and industry rank for Instituto Rosenbusch's Days Inventory or its related term are showing as below:
BUE:ROSE'
s Days Inventory Range Over the Past 10 Years
Min: 157.75 Med: 261.82 Max: 437.47
Current: 157.75
During the past 13 years, Instituto Rosenbusch's highest Days Inventory was 437.47. The lowest was 157.75. And the median was 261.82.
BUE:ROSE's Days Inventory is ranked better than 52.45% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs BUE:ROSE: 157.75
Instituto Rosenbusch's Days Inventory
declined
from Dec. 2024 (251.15) to Dec. 2025 (135.82).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Instituto Rosenbusch's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.67.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Instituto Rosenbusch's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.28.
Instituto Rosenbusch (BUE:ROSE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Instituto Rosenbusch's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Instituto Rosenbusch's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Instituto Rosenbusch Days Inventory Related Terms
Instituto Rosenbusch Days Inventory Historical Data
* Premium members only.
The historical data trend for Instituto Rosenbusch's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUE:ROSE vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Instituto Rosenbusch Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Days Inventory distribution charts can be found below:
* The bar in red indicates where Instituto Rosenbusch's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instituto Rosenbusch (BUE:ROSE) has a Days Inventory of 135.82 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Instituto Rosenbusch and its competitors. This is 48% below median its historical median of 261.82. Over the past decade, Instituto Rosenbusch's Days Inventory has ranged from 157.75 to 437.47. According to the industry distribution chart, Instituto Rosenbusch ranks #437 out of 919 companies in the Drug Manufacturers industry, placing it in the top 47.6%.
Is Instituto Rosenbusch's Days Inventory too high?
Instituto Rosenbusch's current Days Inventory of 135.82 is 48% below median its 10-year median of 261.82. Over the past 10 years, this metric has ranged from a low of 157.75 to a high of 437.47. The Drug Manufacturers industry median Days Inventory is 164.38. Instituto Rosenbusch's value of 135.82 is 17.4% below this industry median. Based on the distribution chart, Instituto Rosenbusch ranks #437 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Instituto Rosenbusch has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Instituto Rosenbusch's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Instituto Rosenbusch ranks #437 out of 919 companies for Days Inventory. This puts Instituto Rosenbusch in the upper half of its industry. The industry median Days Inventory is 164.38. Instituto Rosenbusch's value of 135.82 is 17.4% below this benchmark. Historically, Instituto Rosenbusch's own Days Inventory has ranged from 157.75 to 437.47 over the past decade. While the company's 10-year median is 261.82 vs. the industry median of 164.38, Instituto Rosenbusch has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Instituto Rosenbusch's current Days Inventory of 135.82 is 17.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Instituto Rosenbusch and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Instituto Rosenbusch's current Days Inventory is 135.82, which is 48% below median its own 10-year median of 261.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instituto Rosenbusch stock overvalued right now?
Based on GuruFocus' analysis, Instituto Rosenbusch (BUE:ROSE) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS62.05, compared to a current price of ARS160.00 — trading 157.9% above its estimated fair value. The current Days Inventory is 135.82, which is 48% below median its 10-year median of 261.82 and 17.4% below the Drug Manufacturers industry median of 164.38. Instituto Rosenbusch's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Instituto Rosenbusch (BUE:ROSE), the current Days Inventory is 135.82 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Instituto Rosenbusch (BUE:ROSE) Overvalued in 2026?
Based on GuruFocus' analysis, Instituto Rosenbusch stock appears to be overvalued.
The current stock price of ARS160.00 is trading 157.9% above its estimated GF Value™ of ARS62.05.
GuruFocus considers Instituto Rosenbusch to be Significantly Overvalued.
Key valuation signals for BUE:ROSE:
Days Inventory: 135.82 (48% below median its 10-year median of 261.82)
GF Value™: ARS62.05 vs. price of ARS160.00 (157.9% above fair value)
Industry Position: 17.4% below the Drug Manufacturers median (#437 of 919)
No single metric tells the full story. See the BUE:ROSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
39GF Score
Get the complete analysis for BUE:ROSE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUE:ROSE has been successfully added to your 
